Skip to content
Menu
Tirzepatide (Mounjaro/Zepbound) at Nomi Beach Health -- Endocrinology & Weight Loss

Tirzepatide Weight Loss Program in North Miami Beach

Tirzepatide (Mounjaro/Zepbound) medical weight loss in North Miami Beach. Dual-action GLP-1/GIP therapy for maximum results. Doctor-supervised. Book now.

About Tirzepatide (Mounjaro/Zepbound)

Tirzepatide is the most powerful FDA-approved weight loss medication available today. As a dual GLP-1/GIP receptor agonist (marketed as Mounjaro for diabetes and Zepbound for weight management), Tirzepatide works through two metabolic pathways for superior results. Clinical trials demonstrated average weight loss of 20-25% of body weight — making it the most effective medical weight loss treatment ever studied.

Benefits of Tirzepatide (Mounjaro/Zepbound)

Discover how this treatment can help you achieve your goals.

Average 20-25% body weight loss in trials
Dual-action mechanism for superior efficacy
Significantly reduces appetite
Once-weekly injection
Improves insulin sensitivity and metabolic health
Greater efficacy than Semaglutide in head-to-head trials
Reduces cardiovascular risk

What to Expect

Your step-by-step treatment journey at Nomi Beach Health.

  1. 1

    Comprehensive initial assessment

  2. 2

    Metabolic panel and body composition analysis

  3. 3

    Personalized dosing protocol with gradual titration

  4. 4

    Monthly monitoring appointments

  5. 5

    Nutritional guidance and lifestyle coaching

  6. 6

    Ongoing optimization and maintenance planning

Is Tirzepatide (Mounjaro/Zepbound) Right for You?

Tirzepatide is ideal for adults seeking maximum weight loss results with medical supervision.

  • Adults with BMI 30+ seeking aggressive weight loss
  • Those who haven't achieved desired results with Semaglutide
  • Patients with insulin resistance or type 2 diabetes
  • Those wanting the most effective FDA-approved option

Frequently Asked Questions

Common questions about Tirzepatide (Mounjaro/Zepbound) at Nomi Beach Health.

Tirzepatide targets two receptors (GLP-1 and GIP) instead of one, which clinical trials show leads to greater average weight loss.

Similar to Semaglutide — primarily mild GI symptoms that typically resolve with gradual dose titration.

Ready to Get Started?

Schedule your consultation today and take the first step toward your health and wellness goals.

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Individual results may vary. All treatments are provided under the supervision of licensed medical professionals. Please consult with a qualified healthcare provider to determine whether a treatment is appropriate for your specific needs and medical history.